Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120205 · ClinicalTrials.gov registry record · NA
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
A NA study of Hpv and HPV Infection, sponsored by Teal Health.
- Active
- Registry status
- NA
- Development phase
- 870
- Enrollment target
- 15
- Study locations
NCT06120205 is a NA study of Hpv and HPV Infection that is active but no longer recruiting, run by Teal Health. The registered enrollment target is 870 participants, below the 2,205-participant average among 24 other Hpv trials with a reported enrollment target (61% lower). The trial reports 15 study locations across 12 states.
The verdict
NCT06120205, a NA study of Hpv and HPV Infection, is active but no longer recruiting, sponsored by Teal Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 870 participants
- Enrollment target
- 15
- Study locations
Study Summary
The goal of this method comparison study is to compare the detection of hrHPV collected using the Teal Wand Self-Collection device to hrHPV detected from HCP (health care provider) cervical collection using primary HPV testing assays. Participants will be asked to use the Teal Wand to provide a self-collected sample prior to a healthcare provider collected sample to be tested for hrHPV. Secondary measure will include usability and preferences.
Conditions Studied
Interventions
- DEVICE Teal Wand Self-Collection Device Group
Study Locations (15)
Connecticut
- Planned Parenthood Southern New England - New Haven
- Yale University - New Haven
Missouri
- Planned Parenthood St. Louis Region - St Louis
- Washington University - St Louis
North Carolina
- Unified Women's Clinical Research Raleigh - Raleigh
- Unified Women's Clinical Research - Lyndhurst - Winston-Salem
Alabama
- Birmingham OBGYN / Alabama Clinical Therapeutics - Birmingham
California
- Planned Parenthood Northern California - San Francisco
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Louisiana
- Woman's Hospital - Baton Rouge
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 870 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06120205
The ClinicalTrials.gov registry entry for NCT06120205 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 870 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,205-participant average among 24 other Hpv trials with a reported enrollment target (61% lower). The listed sponsor is Teal Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hpv appearing as the primary indexed condition, and to 1 intervention - of which Teal Wand Self-Collection Device Group is the first listed.
NCT06120205 reports 15 study locations spanning 12 distinct geographic areas - top geographies include Connecticut, Missouri, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06120205 about?
NCT06120205 is a clinical study titled "SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening". The goal of this method comparison study is to compare the detection of hrHPV collected using the Teal Wand Self-Collection device to hrHPV detected from HCP (health care provider) cervical collection using primary HPV testing assays. Participants will be asked to use the Teal Wand to provide a sel...
What is the current status of trial NCT06120205?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 870 participants. The study started on 2023-11-20. Estimated completion is 2027-06-01.
What conditions does trial NCT06120205 study?
This clinical trial studies the following conditions: Hpv, HPV Infection, HPV 16 Infection, High Risk HPV.
What interventions are being tested in trial NCT06120205?
The interventions under investigation include: Teal Wand Self-Collection Device Group (DEVICE).
Who is sponsoring clinical trial NCT06120205?
This trial is sponsored by Teal Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06120205 being conducted?
This trial has 15 study locations across Alabama, California, Colorado, Connecticut, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Playing Game to Learn About Children's Vaccine Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.